Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1990-07-19
1991-12-17
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
562467, A61K 4902, C07C 6334
Patent
active
050733613
ABSTRACT:
6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid marked with tritium; its preparation; and its use as a radioactive marker, in the titration of nuclear receptors of retinoids in the presence of contaminating CRABP, or in the measurement of the affinity of retinoids for these nuclear receptors.
REFERENCES:
French Search Report of FR 89 09778.
Darmon Michel
Shroot Braham
Centre International de Recherches Dermatologiques Galderma (CIR
Maples John S.
LandOfFree
Compound marked with tritium, its preparation and its use in the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compound marked with tritium, its preparation and its use in the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compound marked with tritium, its preparation and its use in the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-834422